Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs

E. A. Leick-Maldonado, F. U. Kay, M. C. Leonhardt, D. I. Kasahara, C. M. Prado, F. T. Fernandes, M. A. Martins, I. F.L.C. Tibério

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Leukotriene receptor antagonists have been demonstrated in several studies to possess bronchodilating and anti-inflammatory properties in asthma. However, there are few experimental studies performed to compare the effects of anti-leukotrienes and glucocorticoids, most used anti-inflammatory agents in asthma. In the present study, we evaluated the effects of treatment with dexamethasone or montelukast on eosinophil and mononuclear cell recruitment in an experimental model of allergen-induced chronic airway inflammation in guinea-pigs (GP). Methods: GP were submitted to increasing concentrations of aerosols of ovalbumin (OVA) twice a week for 4 weeks. After 2 weeks, animals were treated daily with dexamethasone, montelukast or saline solution. After this period, GP were anaesthetized, tracheostomized, mechanically ventilated and challenged with OVA aerosol. Results: Maximal changes of respiratory system resistance and elastance induced by OVA challenge were attenuated by dexamethasone (P < 0.001), but not by montelukast treatment. Neither dexamethasone nor montelukast significantly influenced bronchial oedema formation. Dexamethasone but not montelukast induced a decrease in mononuclear cells in airways (P < 0.001). Eosinophil infiltration in the bronchial wall was reduced by both dexamethasone and montelukast (P < 0.005). Only dexamethasone treatment reduced the levels of exhaled nitric oxide (P < 0.025). Conclusion: Although leukotriene receptor antagonist treatment reduces eosinophil accumulation induced by multiple antigen challenges, glucocorticoid treatment attenuates both eosinophil and mononuclear cell infiltration.

Original languageEnglish (US)
Pages (from-to)145-152
Number of pages8
JournalClinical and Experimental Allergy
Volume34
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

montelukast
Leukotriene Antagonists
Dexamethasone
Glucocorticoids
Guinea Pigs
Theoretical Models
Inflammation
Eosinophils
Ovalbumin
Aerosols
Anti-Inflammatory Agents
Asthma
Leukotrienes
leukotriene D4 receptor
Sodium Chloride
Respiratory System
Allergens
Edema
Nitric Oxide

Keywords

  • Asthma
  • Chronic airway inflammation
  • Corticosteroids
  • Eosinophils
  • Exhaled nitric oxide
  • Experimental models of asthma
  • Leukotriene antagonists
  • Lymphocytes
  • Montelukast

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs. / Leick-Maldonado, E. A.; Kay, F. U.; Leonhardt, M. C.; Kasahara, D. I.; Prado, C. M.; Fernandes, F. T.; Martins, M. A.; Tibério, I. F.L.C.

In: Clinical and Experimental Allergy, Vol. 34, No. 1, 01.01.2004, p. 145-152.

Research output: Contribution to journalArticle

Leick-Maldonado, E. A. ; Kay, F. U. ; Leonhardt, M. C. ; Kasahara, D. I. ; Prado, C. M. ; Fernandes, F. T. ; Martins, M. A. ; Tibério, I. F.L.C. / Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs. In: Clinical and Experimental Allergy. 2004 ; Vol. 34, No. 1. pp. 145-152.
@article{897e7e80a16a4341ad8c10e3ae8b202b,
title = "Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs",
abstract = "Background: Leukotriene receptor antagonists have been demonstrated in several studies to possess bronchodilating and anti-inflammatory properties in asthma. However, there are few experimental studies performed to compare the effects of anti-leukotrienes and glucocorticoids, most used anti-inflammatory agents in asthma. In the present study, we evaluated the effects of treatment with dexamethasone or montelukast on eosinophil and mononuclear cell recruitment in an experimental model of allergen-induced chronic airway inflammation in guinea-pigs (GP). Methods: GP were submitted to increasing concentrations of aerosols of ovalbumin (OVA) twice a week for 4 weeks. After 2 weeks, animals were treated daily with dexamethasone, montelukast or saline solution. After this period, GP were anaesthetized, tracheostomized, mechanically ventilated and challenged with OVA aerosol. Results: Maximal changes of respiratory system resistance and elastance induced by OVA challenge were attenuated by dexamethasone (P < 0.001), but not by montelukast treatment. Neither dexamethasone nor montelukast significantly influenced bronchial oedema formation. Dexamethasone but not montelukast induced a decrease in mononuclear cells in airways (P < 0.001). Eosinophil infiltration in the bronchial wall was reduced by both dexamethasone and montelukast (P < 0.005). Only dexamethasone treatment reduced the levels of exhaled nitric oxide (P < 0.025). Conclusion: Although leukotriene receptor antagonist treatment reduces eosinophil accumulation induced by multiple antigen challenges, glucocorticoid treatment attenuates both eosinophil and mononuclear cell infiltration.",
keywords = "Asthma, Chronic airway inflammation, Corticosteroids, Eosinophils, Exhaled nitric oxide, Experimental models of asthma, Leukotriene antagonists, Lymphocytes, Montelukast",
author = "Leick-Maldonado, {E. A.} and Kay, {F. U.} and Leonhardt, {M. C.} and Kasahara, {D. I.} and Prado, {C. M.} and Fernandes, {F. T.} and Martins, {M. A.} and Tib{\'e}rio, {I. F.L.C.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1111/j.1365-2222.2004.01854.x",
language = "English (US)",
volume = "34",
pages = "145--152",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs

AU - Leick-Maldonado, E. A.

AU - Kay, F. U.

AU - Leonhardt, M. C.

AU - Kasahara, D. I.

AU - Prado, C. M.

AU - Fernandes, F. T.

AU - Martins, M. A.

AU - Tibério, I. F.L.C.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Background: Leukotriene receptor antagonists have been demonstrated in several studies to possess bronchodilating and anti-inflammatory properties in asthma. However, there are few experimental studies performed to compare the effects of anti-leukotrienes and glucocorticoids, most used anti-inflammatory agents in asthma. In the present study, we evaluated the effects of treatment with dexamethasone or montelukast on eosinophil and mononuclear cell recruitment in an experimental model of allergen-induced chronic airway inflammation in guinea-pigs (GP). Methods: GP were submitted to increasing concentrations of aerosols of ovalbumin (OVA) twice a week for 4 weeks. After 2 weeks, animals were treated daily with dexamethasone, montelukast or saline solution. After this period, GP were anaesthetized, tracheostomized, mechanically ventilated and challenged with OVA aerosol. Results: Maximal changes of respiratory system resistance and elastance induced by OVA challenge were attenuated by dexamethasone (P < 0.001), but not by montelukast treatment. Neither dexamethasone nor montelukast significantly influenced bronchial oedema formation. Dexamethasone but not montelukast induced a decrease in mononuclear cells in airways (P < 0.001). Eosinophil infiltration in the bronchial wall was reduced by both dexamethasone and montelukast (P < 0.005). Only dexamethasone treatment reduced the levels of exhaled nitric oxide (P < 0.025). Conclusion: Although leukotriene receptor antagonist treatment reduces eosinophil accumulation induced by multiple antigen challenges, glucocorticoid treatment attenuates both eosinophil and mononuclear cell infiltration.

AB - Background: Leukotriene receptor antagonists have been demonstrated in several studies to possess bronchodilating and anti-inflammatory properties in asthma. However, there are few experimental studies performed to compare the effects of anti-leukotrienes and glucocorticoids, most used anti-inflammatory agents in asthma. In the present study, we evaluated the effects of treatment with dexamethasone or montelukast on eosinophil and mononuclear cell recruitment in an experimental model of allergen-induced chronic airway inflammation in guinea-pigs (GP). Methods: GP were submitted to increasing concentrations of aerosols of ovalbumin (OVA) twice a week for 4 weeks. After 2 weeks, animals were treated daily with dexamethasone, montelukast or saline solution. After this period, GP were anaesthetized, tracheostomized, mechanically ventilated and challenged with OVA aerosol. Results: Maximal changes of respiratory system resistance and elastance induced by OVA challenge were attenuated by dexamethasone (P < 0.001), but not by montelukast treatment. Neither dexamethasone nor montelukast significantly influenced bronchial oedema formation. Dexamethasone but not montelukast induced a decrease in mononuclear cells in airways (P < 0.001). Eosinophil infiltration in the bronchial wall was reduced by both dexamethasone and montelukast (P < 0.005). Only dexamethasone treatment reduced the levels of exhaled nitric oxide (P < 0.025). Conclusion: Although leukotriene receptor antagonist treatment reduces eosinophil accumulation induced by multiple antigen challenges, glucocorticoid treatment attenuates both eosinophil and mononuclear cell infiltration.

KW - Asthma

KW - Chronic airway inflammation

KW - Corticosteroids

KW - Eosinophils

KW - Exhaled nitric oxide

KW - Experimental models of asthma

KW - Leukotriene antagonists

KW - Lymphocytes

KW - Montelukast

UR - http://www.scopus.com/inward/record.url?scp=0842313324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842313324&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2222.2004.01854.x

DO - 10.1111/j.1365-2222.2004.01854.x

M3 - Article

VL - 34

SP - 145

EP - 152

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 1

ER -